Wayne State University Multiple Sclerosis Center

Detroit, Michigan

Academic MS Center
12 Active TrialsLarge Center
8 MS centers statewide · Ranked #1 in Michigan for clinical trials
What kind of place is this?
Comprehensive Care TeamResearch Focused

You are looking at a large academic MS center in Detroit with a team-based approach to care. You may appreciate the mix of MS specialists, rehabilitation support, neuropsychology, and research access in one place. You should be aware that this is a single-location center, so scheduling and access may feel less convenient than at a larger multi-site system.

Facility Profile
Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access2/5
Support Services4/5
Clinical Trials & Research4/5
Insurance & Navigation Help2/5
Scheduling & Virtual Care2/5

About Wayne State University Multiple Sclerosis Center

This center combines care for a large MS patient population with a dedicated neuroimmunology clinical research program.

Wayne State University Multiple Sclerosis Center serves more than 4,000 people with MS and related autoimmune neurologic conditions. The team treats multiple sclerosis, neuromyelitis optica, transverse myelitis, optic neuritis, CNS vasculitis, neurosarcoidosis, ADEM, autoimmune encephalitis, and other autoimmune disorders. Patients benefit from coordinated, team-based care and a strong clinical research program. If you are looking for a large academic center in Detroit with both treatment and research options, this center stands out.

Wayne State University Multiple Sclerosis Center is an academic MS center in Detroit affiliated with Wayne State University. You can expect care from a multidisciplinary team that includes MS specialists, an MS fellow, a nurse practitioner, a physical therapist, a neuropsychologist, registered nurses, and medical assistants. The center also blends treatment with neuroimmunology clinical research, including access to investigational drugs and FDA-approved treatments.

Specialized Programs

neuroimmunology clinical research

Services & Treatments

What They Treat
multiple sclerosisneuromyelitis opticatransverse myelitisoptic neuritisCNS vasculitisneurosarcoidosisacute disseminated encephalomyelitis (ADEM)autoimmune encephalitisother autoimmune disorders
How They Treat It
multiple sclerosis treatmentneuroimmunology clinical researchcompassionate team-based carecoordination with other specialistsclinical trial treatment accessinvestigational drugsFDA-approved treatments

Research & Clinical Trials

This center is currently involved in 12 clinical trials — ranked #1 in Michigan for active trials

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
Ocrelizumab
A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
Ocrelizumab
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
FenebrutinibOcrelizumabPlacebo matched to ocrelizumabPlacebo matched to fenebrutinib
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
Sanofi
ACTIVE NOT RECRUITINGPHASE3
TolebrutinibPlaceboTeriflunomide
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
RemibrutinibTeriflunomide
Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple Sclerosis
Wayne State University
RECRUITING
Observation of Ocrelizumab as Treatment in RRMS Patients
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
OfatumumabTetanus toxoid (TT) containing vaccine (Td, Tdap)13-valent pneumococcal conjugate vaccine (13-PCV)23-valent pneumococcal polysaccharide vaccine (23-PPV)Seasonal Quadrivalent influenza vaccineKeyhole limpet hemocyanin (KLH) neo-antigen
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
National Cancer Institute (NCI)
RECRUITINGPHASE1
Biospecimen CollectionNivolumab
Optimizing Detection and Prediction of Changes in Cognitive Function in Multiple Sclerosis (MS)
University of Michigan
ACTIVE NOT RECRUITING
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
Interferon beta-1aFingolimodPlacebo capsulePlacebo i.m. injection
TRAIN-BW: Backward Walking Training in Multiple Sclerosis
Wayne State University
ACTIVE NOT RECRUITINGNA
Backward Walking TrainingForward Walking Training
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
Johns Hopkins University
ACTIVE NOT RECRUITINGNA
Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsqGlatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod

Insurance & Access

Contact
University Health Center 8A, 4201 St. Antoine, Detroit, MI 48201
Insurance & Support

FAQs from Wayne State University Multiple Sclerosis Center

The center treats multiple sclerosis and several related neuroimmunology conditions, including neuromyelitis optica, transverse myelitis, optic neuritis, CNS vasculitis, neurosarcoidosis, acute disseminated encephalomyelitis, and autoimmune encephalitis.

You are cared for by a multidisciplinary team focused on MS and related autoimmune neurologic conditions. The center also combines treatment with neuroimmunology clinical research.

Yes. Patients can access investigational drugs alongside FDA-approved treatments through its clinical research program.

Appointments are scheduled by phone at (313) 745-4275. That direct phone line is the listed contact for clinic appointments.

Check out the MS Buddy App

Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.

Download on the App StoreGet it on Google Play
Website